节点文献

甲泼尼龙与抑肽酶对心肺转流术致全身炎症反应过程中白细胞磷脂酶D活性的影响(英文)

Effects of methylprednisolone and aprotinin on phospholipase D activity of leukocytes in systemic inflammatory response induced by cardiopulmonary bypass

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 吴明卢韵碧江波徐世伟陈如坤周汉良

【Author】 WU Ming, LU Yun-Bi, JIANG Bo, XU Shi-Wei, CHEN Ru-Kun , ZHOU Han-Liang(Department of Cardiovascular Thoracic Surgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009; Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou 310031, China )

【机构】 浙江大学医学院附属第二医院心胸外科浙江大学医学院药理教研室浙江大学医学院药理教研室 杭州 310009杭州中国 310031杭州 310009中国 310031

【摘要】 目的:探讨白细胞磷脂酶D(PLD)在心肺转流术(CPB)致全身性炎症反应过程中的作用及甲泼尼龙和抑肽酶对PLD活性的影响。方法:42例接受CPB心脏直视手术病人,分为对照组、甲泼尼龙组和抑肽酶组,患者于术前、心肺转流术中及术后8个不同时点采集动脉血,测定白细胞PLD活性,并检测髓过氧化物酶活性、CD11b表达及血浆IL-6、IL-8和C-反应蛋白的含量。结果:在升主动脉开放时点,对照组白细胞PLD活性为(18±8)nmol choline·h-1·mg-1,明显高于术前;甲泼尼龙组为(10±6)nmol choline·h-1·mg-1,明显低于对照组,但与术前相比差别无显著意义;甲泼尼龙组白细胞PLD活性升高时点后移至停CPB即刻点;抑肽酶组PLD活性与对照组相比差别无显著意义;但两药均不同程度降低CPB围术期血浆中IL-6、IL-8和C-反应蛋白水平及MRO活性、白细胞CD11b表达。结论:CPB致全身炎症反应过程中白细胞的PLD活性持续升高;甲泼尼龙部分抑制CPB引起的炎症反应,其抗炎机制与抑制PLD有关。

【Abstract】 AIM: To investigate the role of leukocyte phoshpolipase D (PLD) in systemic inflammatory response induced by cardiopulmonary bypass ( CPB) and the effects of methylprednisolone and aprotinin on leukocyte PLD activity. METHODS: Forty-two patients who received CPB open heart surgery were divided into 3 groups; methylprednisolone group, aprotinin group, and control group. Arterial blood (10 mL) was collected for assay of leukocyte PLD activity, myeloperoxidase ( MPO) activity, and CD11b expression at 8 different time points in perioperative period. Plasma IL-6, IL-8, and C-reactive protein levels were also determined. RESULTS: At the time point of ascending aorta declamped, leukocyte PLD activity for control group was (18 + 8) nmol choline·h-1·mg-1, which was higher than that of pre-CPB (P <0.01); the PLD activity for methylprednisolone group was (10+6) nmol choline·h-1·mg-1 that was lower than control ( P < 0.05), while it had no statistical difference compared with that of pre-CPB. In methylprednisolone group, PLD activity elevation was postponed to the time point of CPB stopped. There was no statistical difference in PLD activity between aprotinin group and control (P > 0.05). After administration of methylprednisolone or aprotinin, leukocyte CD11b expression, plasma IL-6, IL-8, C-reactive proteinlevels, and MPO activity decreased by different extent. CONCLUSION: Leukocyte PLD activity was elevated significantly in systemic inflammatory response induced by CPB and methylprednisolone partially blunted the CPB-induced inflammatory response by inhibiting PLD activity.

【基金】 Project supported by the National Natural Science Foundation of China, No 39670836
  • 【文献出处】 Acta Pharmacologica Sinica ,中国药理学报(英文版) , 编辑部邮箱 ,2001年10期
  • 【分类号】R96
  • 【被引频次】4
  • 【下载频次】25
节点文献中: 

本文链接的文献网络图示:

本文的引文网络